Page last updated: 2024-11-04

terbutaline and Alzheimer Disease

terbutaline has been researched along with Alzheimer Disease in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, S1
Li, AJ1
Travers, J1
Xu, T1
Sakamuru, S1
Klumpp-Thomas, C1
Huang, R1
Xia, M1

Other Studies

1 other study available for terbutaline and Alzheimer Disease

ArticleYear
Identification of Compounds for Butyrylcholinesterase Inhibition.
    SLAS discovery : advancing life sciences R & D, 2021, Volume: 26, Issue:10

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inh

2021